Erythromycin

C. diff Risk

None

Oral Bioavailability

NA

Approximate Cost

Spectrum Of Activity

Dosing

500 mg PO QID

No dose adjustment

General Information

Major Interactions

Erythromycin is a major inhibitor of CYP3A4. Consult a drug interactions database for more detailed information.

Other drugs that prolong QTc.

Increases cyclosporine levels.

Statins increased risk of rhabdomyolysis.

Increases INR with warfarin.